Polish Technology Groupsp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2019-11-12
Share capital
5,000.00 PLN
Registered address
Aleja Prymasa Tysiąclecia 83A/102, 01-242 Warszawa, Poland
Electronic delivery address
AE:PL-26734-75267-UUDCH-14
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 369 days for 2022).
- 2025not filed
- 202415/07/2025
- 202318/07/2024
- 202218/07/2024
- 202117/10/2022
- 202014/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 11.06kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -14.50kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 25.54kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 609.59kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Tomasz Pałasz – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Przemysław Godlewskiage 32 | 10 | $135.06 | 10% |
Tomasz Pałaszage 41 | 90 | $1,215.56 | 90% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-02-02.
46 1090 1014 0000 0001 4395 9715
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 19, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-07 | Address change (Ul. Wojciecha Górskiego 6/75, 00-033, Warszawa → Aleja Prymasa Tysiąclecia 83a/102, 01-242, Warszawa) | |
| 2020-02-24 | Address change (Ul. Wojciecha Górskiego 6/75, 05-077, Warszawa → Ul. Wojciecha Górskiego 6/75, 00-033, Warszawa) | |
| 2019-11-12 | Entered in the register |
FAQ
The main business activity of Polish Technology Group focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on November 12, 2019.
The headquarters is located at: Aleja Prymasa Tysiąclecia 83A, 01-242 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of USD 11,061, representing a decrease of 58.1% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of USD 14,496. For comparison, in 2023 the loss was USD 34,508, meaning the company reduced its loss by 60.1%.
The largest operating cost category falls under other operating costs. This category amounted to USD 25,483 in 2024, representing 100% of all operating expenses.
Last updated: 2026-08-07